{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T04:14:00Z","timestamp":1774498440599,"version":"3.50.1"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:00:00Z","timestamp":1649203200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>There is limited knowledge about the risk of non-alcoholic fatty liver disease (NAFLD) associated with cardiometabolic disorders in lean persons. This study examines the contribution of cardiometabolic disorders to NAFLD risk among lean individuals and compares to non-lean individuals.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>We analyzed longitudinal data from 6,513 participants of a yearly voluntary routine health testing conducted at the Hospital Israelita Albert Einstein, Brazil. NAFLD was defined as hepatic ultrasound diagnosed fatty liver in individuals scoring below 8 on the alcohol use disorders identification test. Our main exposure variables were elevated blood glucose, elevated blood pressure (BP), presence of atherogenic dyslipidemia (AD, defined as the combination of elevated triglycerides and low HDL cholesterol) and physical inactivity (&lt;150 minutes\/week of moderate activity). We further assessed the risk of NAFLD with elevations in waist circumference and high sensitivity C-reactive protein (HsCRP).<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>Over 15,580 person-years (PY) of follow-up, the incidence rate of NAFLD was 7.7 per 100 PY. In multivariate analysis adjusting for likely confounders, AD was associated with a 72% greater risk of NAFLD (IRR: 1.72 [95% CI:1.32\u20132.23]). Elevated blood glucose (IRR: 1.71 [95%CI: 1.29\u20132.28]) and physical inactivity (IRR: 1.46 [95%CI: 1.28\u20131.66]) were also independently associated with increased risk of NAFLD. In lean individuals, AD, elevated blood glucose and elevated BP were significantly associated with NAFLD although for elevated blood glucose, statistical significance was lost after adjusting for possible confounders. Physical inactivity and elevations in HsCRP were not associated with the risk of NAFLD in lean individuals only. Among lean (and non-lean) individuals, there was an independent association between progressively increasing waist circumference and NAFLD.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusion<\/jats:title><jats:p>Cardiometabolic risk factors are independently associated with NAFLD. However, there are significant differences in the metabolic risk predictors of NAFLD between lean and non-lean individuals. Personalized cardiovascular disease risk stratification and appropriate preventive measures should be considered in both lean and non-lean individuals to prevent the development of NAFLD.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0266505","type":"journal-article","created":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T17:44:07Z","timestamp":1649267047000},"page":"e0266505","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cardiometabolic disorders, inflammation and the incidence of non-alcoholic fatty liver disease: A longitudinal study comparing lean and non-lean individuals"],"prefix":"10.1371","volume":"17","author":[{"given":"Ehimen C.","family":"Aneni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0642-1968","authenticated-orcid":true,"given":"Gul Jana","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio Sommer","family":"Bittencourt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel","family":"Cainzos-Achirica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chukwuemeka U.","family":"Osondu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9616-1946","authenticated-orcid":true,"given":"Matthew","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edison R.","family":"Parise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9860-6582","authenticated-orcid":true,"given":"Raul D.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khurram","family":"Nasir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,4,6]]},"reference":[{"issue":"6","key":"pone.0266505.ref001","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1002\/hep.25762","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"55","author":"N Chalasani","year":"2012","journal-title":"Hepatology"},{"issue":"1","key":"pone.0266505.ref002","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease\u2014Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"pone.0266505.ref003","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention","volume":"15","author":"Z Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"pone.0266505.ref004","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"178","author":"Mariana Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"issue":"6","key":"pone.0266505.ref005","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the United States","volume":"91","author":"ZM Younossi","year":"2012","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"pone.0266505.ref006","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/cd18-0026","article-title":"Patients With Lean Nonalcoholic Fatty Liver Disease Are Metabolically Abnormal and Have a Higher Risk for Mortality","volume":"37","author":"P Golabi","year":"2019","journal-title":"Clinical Diabetes"},{"issue":"2","key":"pone.0266505.ref007","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.cgh.2015.08.010","article-title":"Trends in the Burden of Nonalcoholic Fatty Liver Disease in a United States Cohort of Veterans","volume":"14","author":"F Kanwal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"pone.0266505.ref008","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/01.CIR.0000154900.76284.F6","article-title":"Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research","volume":"111","author":"TG Pickering","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"pone.0266505.ref009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7863\/jum.1984.3.1.9","article-title":"Fatty infiltration of the liver: ultrasonographic and computed tomographic correlation","volume":"3","author":"JC Scatarige","year":"1984","journal-title":"J Ultrasound Med"},{"issue":"4","key":"pone.0266505.ref010","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1530-0277.1997.tb03811.x","article-title":"A review of research on the Alcohol Use Disorders Identification Test (AUDIT)","volume":"21","author":"JP Allen","year":"1997","journal-title":"Alcohol Clin Exp Res"},{"key":"pone.0266505.ref011","volume-title":"Stata Statistical Software: Release 16 [computer program]","year":"2019"},{"issue":"1","key":"pone.0266505.ref012","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"ZM Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"5","key":"pone.0266505.ref013","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1002\/hep.29546","article-title":"Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study","volume":"67","author":"AM Allen","year":"2018","journal-title":"Hepatology"},{"key":"pone.0266505.ref014","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","article-title":"Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics","volume":"92","author":"SA Polyzos","year":"2019","journal-title":"Metabolism\u2014Clinical and Experimental"},{"issue":"6","key":"pone.0266505.ref015","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1301\/nr.2007.jun.S57-S63","article-title":"nonalcoholic fatty liver disease","volume":"65","author":"Angulo P. Obesity","year":"2007","journal-title":"Nutr Rev"},{"key":"pone.0266505.ref016","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","author":"Q Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"pone.0266505.ref017","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2016.09.022","article-title":"Bi-directional analysis between fatty liver and cardiovascular disease risk factors","volume":"66","author":"J Ma","year":"2017","journal-title":"J Hepatol"},{"issue":"11","key":"pone.0266505.ref018","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1111\/liv.13478","article-title":"Incidence and risk factors for non-alcoholic fatty liver disease: A 7-year follow-up study among urban, adult Sri Lankans","volume":"37","author":"MA Niriella","year":"2017","journal-title":"Liver Int"},{"key":"pone.0266505.ref019","article-title":"Lean non-alcoholic fatty liver disease (lean NAFLD): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka","volume":"13","author":"MA Niriella","year":"2018","journal-title":"Hepatology International"},{"issue":"5","key":"pone.0266505.ref020","doi-asserted-by":"crossref","first-page":"E1033","DOI":"10.1152\/ajpendo.00291.2011","article-title":"Effects of aerobic vs. resistance training on visceral and liver fat stores, liver enzymes, and insulin resistance by HOMA in overweight adults from STRRIDE AT\/RT","volume":"301","author":"CA Slentz","year":"2011","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"pone.0266505.ref021","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/jgh.13965","article-title":"Physical activity levels and hepatic steatosis: A longitudinal follow-up study in adults","volume":"33","author":"AM Gerage","year":"2018","journal-title":"Journal of Gastroenterology and Hepatology"},{"issue":"2","key":"pone.0266505.ref022","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.atherosclerosis.2015.02.011","article-title":"The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"239","author":"M Al Rifai","year":"2015","journal-title":"Atherosclerosis"},{"issue":"1","key":"pone.0266505.ref023","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0038-1677517","article-title":"NASH in Lean Individuals","volume":"39","author":"R Younes","year":"2019","journal-title":"Semin Liver Dis"},{"issue":"7","key":"pone.0266505.ref024","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"QM Anstee","year":"2019","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"issue":"4","key":"pone.0266505.ref025","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.cgh.2018.05.057","article-title":"Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates","volume":"17","author":"Z Younossi","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"5","key":"pone.0266505.ref026","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.3390\/nu5051544","article-title":"Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease","volume":"5","author":"M Gaggini","year":"2013","journal-title":"Nutrients"},{"issue":"6","key":"pone.0266505.ref027","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cgh.2011.12.039","article-title":"Independent association between nonalcoholic fatty liver disease and cardiovascular disease in the US population","volume":"10","author":"M Stepanova","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"6","key":"pone.0266505.ref028","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"QM Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"10","key":"pone.0266505.ref029","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1007\/s10620-013-2743-5","article-title":"Predictors of all-cause mortality and liver-related mortality in patients with non-alcoholic fatty liver disease (NAFLD)","volume":"58","author":"M Stepanova","year":"2013","journal-title":"Dig Dis Sci"},{"issue":"36","key":"pone.0266505.ref030","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.3748\/wjg.v23.i36.6571","article-title":"Nonalcoholic fatty liver disease: Evolving paradigms","volume":"23","author":"A Lonardo","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"3","key":"pone.0266505.ref031","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis","volume":"54","author":"R Hernaez","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"pone.0266505.ref032","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/j.jhep.2009.09.001","article-title":"Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study","volume":"51","author":"S Dasarathy","year":"2009","journal-title":"J Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266505","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T18:43:03Z","timestamp":1700419383000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0266505"}},"subtitle":[],"editor":[{"given":"Martin","family":"Senechal","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,4,6]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,4,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0266505","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,6]]}}}